These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 38833260

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity.
    Duncan JL, Liang W, Maguire MG, Audo I, Ayala AR, Birch DG, Carroll J, Cheetham JK, Esposti SD, Durham TA, Erker L, Farsiu S, Ferris FL, Heon E, Hufnagel RB, Iannaccone A, Jaffe GJ, Kay CN, Michaelides M, Pennesi ME, Sahel JA, Foundation Fighting Blindness Consortium Investigator Group.
    Am J Ophthalmol; 2020 Nov; 219():87-100. PubMed ID: 32446738
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Correlations between the Michigan Retinal Degeneration Questionnaire and visual function parameters in patients with retinitis pigmentosa.
    Karuntu JS, Nguyen XT, Boon CJF.
    Acta Ophthalmol; 2024 Aug; 102(5):555-563. PubMed ID: 38158751
    [Abstract] [Full Text] [Related]

  • 5. The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline.
    Birch DG, Cheng P, Duncan JL, Ayala AR, Maguire MG, Audo I, Cheetham JK, Durham TA, Fahim AT, Ferris FL, Heon E, Huckfeldt RM, Iannaccone A, Khan NW, Lad EM, Michaelides M, Pennesi ME, Stingl K, Vincent A, Weng CY, Foundation Fighting Blindness Consortium Investigator Group.
    Transl Vis Sci Technol; 2020 Oct; 9(11):9. PubMed ID: 33133772
    [Abstract] [Full Text] [Related]

  • 6. Functional Vision in Patients With Biallelic USH2A Variants.
    Heon E, Melia M, Bocchino LE, Samarakoon L, Duncan JL, Ayala AR, Audo I, Bradley C, Cheetham JK, Dagnelie G, Durham TA, Hoyng CB, Jain N, Jayasundera KT, Pennesi ME, Weng CY, Foundation Fighting Blindness Consortium Investigator Group.
    Am J Ophthalmol; 2024 Apr; 260():200-211. PubMed ID: 38135239
    [Abstract] [Full Text] [Related]

  • 7. Spectral-Domain Optical Coherence Tomography Analysis in Syndromic and Nonsyndromic Forms of Retinitis Pigmentosa due to USH2A Genetic Variants.
    Colombo L, Maltese PE, Romano D, Fogagnolo P, Castori M, Marceddu G, Cristofoli F, Percio M, Piteková B, Modarelli AM, Bertelli M, Rossetti L.
    Ophthalmic Res; 2022 Apr; 65(2):180-195. PubMed ID: 34781295
    [Abstract] [Full Text] [Related]

  • 8. Cone Structure and Function in RPGR- and USH2A-Associated Retinal Degeneration.
    Micevych PS, Wong J, Zhou H, Wang RK, Porco TC, Carroll J, Roorda A, Duncan JL.
    Am J Ophthalmol; 2023 Jun; 250():1-11. PubMed ID: 36646238
    [Abstract] [Full Text] [Related]

  • 9. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.
    Pierrache LH, Hartel BP, van Wijk E, Meester-Smoor MA, Cremers FP, de Baere E, de Zaeytijd J, van Schooneveld MJ, Cremers CW, Dagnelie G, Hoyng CB, Bergen AA, Leroy BP, Pennings RJ, van den Born LI, Klaver CC.
    Ophthalmology; 2016 May; 123(5):1151-60. PubMed ID: 26927203
    [Abstract] [Full Text] [Related]

  • 10. Self-reported visual function and psychosocial impact of visual loss in EYS-associated retinal degeneration in a Portuguese population.
    Marques JP, Machado Soares R, Simão S, Abuzaitoun R, Andrews C, Alves CH, Ambrósio AF, Murta J, Silva R, Abalem MF, Jayasundera KT.
    Ophthalmic Genet; 2023 Aug; 44(4):334-340. PubMed ID: 36946380
    [Abstract] [Full Text] [Related]

  • 11. Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 Years.
    Duncan JL, Cheng P, Maguire MG, Ayala AA, Birch DG, Cheetham JK, Durham TA, Fahim AT, Hoyng CB, Ishikawa H, Michaelides M, Pennesi ME, Sahel JA, Stingl K, Weng CY, Foundation Fighting Blindness Consortium Investigator Group.
    Am J Ophthalmol; 2023 Jun; 250():103-110. PubMed ID: 36764426
    [Abstract] [Full Text] [Related]

  • 12. Endpoints and Design for Clinical Trials in USH2A-Related Retinal Degeneration: Results and Recommendations From the RUSH2A Natural History Study.
    Maguire MG, Birch DG, Duncan JL, Ayala AR, Ayton LN, Cheetham JK, Cheng P, Durham TA, Ferris FL, Hoyng CB, Huckfeldt RM, Jaffe GJ, Kay C, Lad EM, Leroy BP, Liang W, McDaniel LS, Melia M, Michaelides M, Pennesi ME, Sahel JA, Samarakoon L, REDI Working Group and the Foundation Fighting Blindness Clinical Consortium Investigator Group.
    Transl Vis Sci Technol; 2024 Oct 01; 13(10):15. PubMed ID: 39382872
    [Abstract] [Full Text] [Related]

  • 13. Exploring self-reported visual function and vision-related anxiety in patients with RPGR-associated retinal degeneration.
    Gouveia N, Chukwunalu O, Oliveira C, Alves CH, Silva R, Murta J, Marques JP.
    Sci Rep; 2024 Jul 02; 14(1):15189. PubMed ID: 38956231
    [Abstract] [Full Text] [Related]

  • 14. The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene.
    Birch DG, Samarakoon L, Melia M, Duncan JL, Ayala AR, Audo I, Cheetham JK, Durham TA, Iannaccone A, Pennesi ME, Stingl K, Foundation Fighting Blindness Consortium Investigator Group.
    Invest Ophthalmol Vis Sci; 2022 Mar 02; 63(3):17. PubMed ID: 35293952
    [Abstract] [Full Text] [Related]

  • 15. Baseline Microperimetry and OCT in the RUSH2A Study: Structure-Function Association and Correlation With Disease Severity.
    Lad EM, Duncan JL, Liang W, Maguire MG, Ayala AR, Audo I, Birch DG, Carroll J, Cheetham JK, Durham TA, Fahim AT, Loo J, Deng Z, Mukherjee D, Heon E, Hufnagel RB, Guan B, Iannaccone A, Jaffe GJ, Kay CN, Michaelides M, Pennesi ME, Vincent A, Weng CY, Farsiu S, Foundation Fighting Blindness Consortium Investigator Group.
    Am J Ophthalmol; 2022 Dec 02; 244():98-116. PubMed ID: 36007554
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phenotypic and Genetic Characteristics in a Cohort of Patients with Usher Genes.
    Feenstra HM, Al-Khuzaei S, Shah M, Broadgate S, Shanks M, Kamath A, Yu J, Jolly JK, MacLaren RE, Clouston P, Halford S, Downes SM.
    Genes (Basel); 2022 Aug 10; 13(8):. PubMed ID: 36011334
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical and preclinical therapeutic outcome metrics for USH2A-related disease.
    Toms M, Dubis AM, de Vrieze E, Tracey-White D, Mitsios A, Hayes M, Broekman S, Baxendale S, Utoomprurkporn N, Bamiou D, Bitner-Glindzicz M, Webster AR, Van Wijk E, Moosajee M.
    Hum Mol Genet; 2020 Jul 21; 29(11):1882-1899. PubMed ID: 31998945
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.